Silver Point Capital
Silver Point Capital, L.P., established in 2002 and headquartered in Greenwich, Connecticut, is a private investment firm specializing in distressed debt and credit-focused investments. Founded by Edward Mulé and Robert O’Shea, the firm targets complex financial situations that require extensive analytical capabilities and prompt execution. Silver Point manages assets across various synergistic credit strategies, including direct lending, capital solutions, credit market opportunities, special situations, structured credit, real estate lending, and opportunistic real estate. With a team of over 320 employees, Silver Point is well-equipped to navigate the intricacies of the credit market and capitalize on investment opportunities that present natural barriers to entry.
Private Equity Round in 2017
PatientPoint is a leader in patient and physician engagement solutions, focusing on enhancing interactions at the point of care. The company specializes in creating tailored health information content that addresses the specific needs of patients in various healthcare settings, including primary care, specialty practices, urgent care clinics, and hospitals. Their award-winning programs integrate patient engagement experiences and have received recognition from the National Health Information Awards for their clarity and effectiveness in consumer health education. PatientPoint's platform also facilitates patient acquisition and engagement through in-office visits, remote care analytics, and customized programs, ultimately aiming to improve health outcomes and foster stronger relationships between healthcare providers and patients.
Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.
Imperium Renewables, Inc., together with its subsidiary, produces and markets biodiesel in the United States. The company produces biodiesel from feedstock oils; and glycerin, a by-product of biodiesel. Its biodiesel is used as alternative fuel in cars, trucks, ships, trains, and planes. The company markets its products through a network of distributors. Imperium Renewables, Inc. was formerly known as Seattle Biodiesel, LLC and changed its name to Imperium Renewables, Inc. in May 2005. The company was founded in 2004 and is based in Seattle, Washington. It has production facilities in Hoquiam, Washington; and Oahu, Hawaii.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.